Literature DB >> 7193039

Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy.

D Pitcher, R Wainwright, M Maisey, P Curry, E Sowton.   

Abstract

Exercise thallium-201 myocardial scintigraphy was performed in 23 patients with hypertrophic cardiomyopathy. Eighteen patients presented with chest pain which was a persistent symptom in 11. Selective coronary arteriography was performed in 16 patients and showed normal coronary arteries in 15 and insignificant luminal irregularities in one patient. Eighteen patients had abnormal scintigrams. Three had an abnormal distribution of tracer entirely attributable to asymmetric septal hypertrophy, whereas 15 had discrete tracer uptake defects which could not be explained solely by myocardial hypertrophy. In this latter group of patients three scintigraphic patterns were identified: (1) in 10 patients defects were seen in scintigrams immediately after exercise but not in delayed images obtained four to six hours later. Eight of these patients had chest pain. (2) Four patients had uptake defects seen in both initial and delayed images. One patient had chest pain. (3) In three patients, one of whom had chest pain, tracer defects were seen only in delayed images and were not apparent in the initial scintigrams. Chest pain occurred in eight out of 10 patients with scintigraphic evidence of myocardial ischaemia but was present in only three out of 13 patients with non-ischaemic scintigrams. The value of exercise thallium-201 myocardial imaging as a diagnostic technique in hypertrophic cardiomyopathy appears limited. Scintigraphic evidence of regional myocardial ischaemia in the absence of significant coronary artery disease, however, contributes to an understanding of the mechanism of angina production in patients with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7193039      PMCID: PMC482461          DOI: 10.1136/hrt.44.6.650

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

Authors:  J E Sanderson; D G Gibson; D J Brown; J F Goodwin
Journal:  Br Heart J       Date:  1977-06

2.  Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion.

Authors:  H W Strauss; K Harrison; J K Langan; E Lebowitz; B Pitt
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history.

Authors:  S Frank; E Braunwald
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

4.  Idiopathic hypertrophic subaortic stenosis: detection by thallium 201 myocardial perfusion imaging.

Authors:  B H Bulkley; J Rouleau; H W Strauss; B Pitt
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

5.  Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia.

Authors:  W C Roberts; V J Ferrans
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

6.  Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.

Authors:  G M Pohost; L M Zir; R H Moore; K A McKusick; T E Guiney; G A Beller
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

7.  Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease.

Authors:  I K Bailey; L S Griffith; J Rouleau; W Strauss; B Pitt
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

8.  Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

9.  The effect of ischemia on thallium-201 clearance from the myocardium.

Authors:  H Gewirtz; D D O'Keefe; G M Pohost; H W Strauss; J B McIlduff; W M Daggett
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

10.  Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis.

Authors:  M G Sutton; A J Tajik; D G Gibson; D J Brown; J B Seward; E R Guiliani
Journal:  Circulation       Date:  1978-03       Impact factor: 29.690

  10 in total
  14 in total

1.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.

Authors:  Felix Y j Keng; Su Min Chang; Eduardo Cwajg; Zuo-Xiang He; Nasser M Lakkis; Sherif F Nagueh; William H Spencer; Mario S Verani
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 3.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

4.  Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy.

Authors:  Mareomi Hamada; Akiyoshi Ogimoto; Kiyotaka Ohshima; Shigehiro Miyazaki; Norio Kubota; Shuntarto Ikeda; Yuji Shigematsu
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

5.  Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; G M Rosano; J S Gill; P A Poole-Wilson; J C Kaski; W J McKenna
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

6.  Reversible ischaemia in hypertrophic cardiomyopathy.

Authors:  H Thomson; W Fong; W Stafford; M Frenneaux
Journal:  Br Heart J       Date:  1995-09

7.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

8.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

9.  Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Enrique Galve; Lluís Armadans; Francisca Ramos; Joan Castell; Santiago Aguadé; Juan M Nogales; Jordi Soler-Soler
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

10.  Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.

Authors:  Nitesh Sood; Firas Al Badarin; Matthew Parker; Raja Pullatt; Arnold F Jacobson; Timothy M Bateman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-07-18       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.